[go: up one dir, main page]

FR2769915B1 - Derives d'indazole tricycliques, leur preparation et leur application en therapeutique - Google Patents

Derives d'indazole tricycliques, leur preparation et leur application en therapeutique

Info

Publication number
FR2769915B1
FR2769915B1 FR9713149A FR9713149A FR2769915B1 FR 2769915 B1 FR2769915 B1 FR 2769915B1 FR 9713149 A FR9713149 A FR 9713149A FR 9713149 A FR9713149 A FR 9713149A FR 2769915 B1 FR2769915 B1 FR 2769915B1
Authority
FR
France
Prior art keywords
preparation
therapeutic application
indazole derivatives
tricyclic indazole
tricyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9713149A
Other languages
English (en)
Other versions
FR2769915A1 (fr
Inventor
Luc Even
Claudie Gautier
Michel Aletru
Philippe R Bovy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9713149A priority Critical patent/FR2769915B1/fr
Application filed by Synthelabo SA filed Critical Synthelabo SA
Priority to EP98950149A priority patent/EP1025109A1/fr
Priority to JP2000516974A priority patent/JP2001520231A/ja
Priority to PCT/FR1998/002221 priority patent/WO1999020633A1/fr
Priority to AU96330/98A priority patent/AU9633098A/en
Priority to CO98060914A priority patent/CO4990933A1/es
Priority to TW087117333A priority patent/TW407160B/zh
Priority to ARP980105207A priority patent/AR017366A1/es
Priority to ZA989556A priority patent/ZA989556B/xx
Publication of FR2769915A1 publication Critical patent/FR2769915A1/fr
Application granted granted Critical
Publication of FR2769915B1 publication Critical patent/FR2769915B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FR9713149A 1997-10-21 1997-10-21 Derives d'indazole tricycliques, leur preparation et leur application en therapeutique Expired - Fee Related FR2769915B1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR9713149A FR2769915B1 (fr) 1997-10-21 1997-10-21 Derives d'indazole tricycliques, leur preparation et leur application en therapeutique
JP2000516974A JP2001520231A (ja) 1997-10-21 1998-10-16 ベンゾオキサジン誘導体、その製造およびその治療における適用
PCT/FR1998/002221 WO1999020633A1 (fr) 1997-10-21 1998-10-16 Derives de benzoxazine, leur preparation et leur application en therapeutique
AU96330/98A AU9633098A (en) 1997-10-21 1998-10-16 Benzoxazine derivatives, preparation and application in therapy
EP98950149A EP1025109A1 (fr) 1997-10-21 1998-10-16 Derives de benzoxazine, leur preparation et leur application en therapeutique
CO98060914A CO4990933A1 (es) 1997-10-21 1998-10-20 Derivados de indazol triciclicos, su preparacion y su apli- cacion en terapeutica
TW087117333A TW407160B (en) 1997-10-21 1998-10-20 Tricyclic indazole derivative compounds, processes for the preparation thereof and pharmaceutical compositions comprising the compounds
ARP980105207A AR017366A1 (es) 1997-10-21 1998-10-20 Un compuesto derivado de 7,8-dihidropirazol[1,5,4-de][1,4]benzoxazina, procedimiento para prepararlo, medicamento, constituido por dicho compuestoy composicion farmaceutica que contiene a dicho compuesto.
ZA989556A ZA989556B (en) 1997-10-21 1998-10-20 Benzoxazine derivatives their preparation and their therapeutic application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9713149A FR2769915B1 (fr) 1997-10-21 1997-10-21 Derives d'indazole tricycliques, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
FR2769915A1 FR2769915A1 (fr) 1999-04-23
FR2769915B1 true FR2769915B1 (fr) 2000-10-13

Family

ID=9512452

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9713149A Expired - Fee Related FR2769915B1 (fr) 1997-10-21 1997-10-21 Derives d'indazole tricycliques, leur preparation et leur application en therapeutique

Country Status (9)

Country Link
EP (1) EP1025109A1 (fr)
JP (1) JP2001520231A (fr)
AR (1) AR017366A1 (fr)
AU (1) AU9633098A (fr)
CO (1) CO4990933A1 (fr)
FR (1) FR2769915B1 (fr)
TW (1) TW407160B (fr)
WO (1) WO1999020633A1 (fr)
ZA (1) ZA989556B (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7081239B2 (en) 1995-05-17 2006-07-25 Cedars-Sinai Medical Center Burns And Allen Research Center Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia
US7452857B2 (en) 1999-08-11 2008-11-18 Cedars-Sinai Medical Center Methods of treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6558708B1 (en) * 1995-05-17 2003-05-06 Cedars-Sinai Medical Center Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia
FR2792318B1 (fr) * 1999-04-16 2001-06-15 Synthelabo Derives d'indazole, leur preparation et leur application en therapeutique
AR036040A1 (es) 2001-06-12 2004-08-04 Upjohn Co Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen
US6911543B2 (en) 2001-10-02 2005-06-28 Pfizer Inc. Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
JP2005510523A (ja) 2001-11-09 2005-04-21 ファルマシア アンド アップジョン カンパニー リミティド ライアビリティー カンパニー アザ二環式フェニル縮合複素環式化合物、及びα７ＮＡＣＨＲリガンドとしての当該化合物の使用
JP2005523288A (ja) 2002-02-19 2005-08-04 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 疾病治療用の縮合した二環式−ｎ−架橋−複素環式芳香族カルボキサミド
AU2003217275A1 (en) 2002-02-19 2003-09-09 Pharmacia And Upjohn Company Azabicyclic compounds for the treatment of disease
TW200533348A (en) 2004-02-18 2005-10-16 Theravance Inc Indazole-carboxamide compounds as 5-ht4 receptor agonists
TWI351282B (en) 2004-04-07 2011-11-01 Theravance Inc Quinolinone-carboxamide compounds as 5-ht4 recepto
US7728006B2 (en) 2004-04-07 2010-06-01 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
US8309575B2 (en) 2004-04-07 2012-11-13 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
DE602005016446D1 (de) 2004-11-05 2009-10-15 Theravance Inc 5-HT4-Rezeptoragonistenverbindungen
ES2327142T3 (es) 2004-11-05 2009-10-26 Theravance, Inc. Compuestos de quinolinona-carboxamida.
WO2006069097A2 (fr) * 2004-12-22 2006-06-29 Memory Pharmaceuticals Corporation Ligands du recepteur alpha-7 nicotinique ainsi que preparation et utilisations de ceux-ci
ES2347265T3 (es) 2004-12-22 2010-10-27 Theravance, Inc. Compuestos de indazol-carboxamida.
EP1871772B1 (fr) 2005-03-02 2014-09-10 Theravance, Inc. Composes de quinolinone en tant qu'agonistes des recepteurs de 5-ht4
JP4375749B2 (ja) 2005-11-22 2009-12-02 本田技研工業株式会社 車両の樹脂製ガーニッシュ構造
WO2007120599A2 (fr) * 2006-04-12 2007-10-25 Wyeth Dérivés de dihydro[1,4]oxazino[2,3,4-hi]indazole en tant que ligands de 5-hydroxytryptamine-6

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4950759A (en) * 1988-07-07 1990-08-21 Duphar International Research B.V. Substituted 1,7-annelated 1H-indazoles
FR2753196B1 (fr) * 1996-09-12 1998-10-23 Synthelabo Derives d'indazole tricyclique, leur preparation et leur application en therapeutique

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7081239B2 (en) 1995-05-17 2006-07-25 Cedars-Sinai Medical Center Burns And Allen Research Center Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia
US7452857B2 (en) 1999-08-11 2008-11-18 Cedars-Sinai Medical Center Methods of treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US7585838B2 (en) 1999-08-11 2009-09-08 Cedars-Sinai Medical Center Methods of treating fibromyalgia caused by small intestinal bacterial overgrowth
US7605240B2 (en) 1999-08-11 2009-10-20 Cedara-Sinai Medical Center Methods of treating diarrhea and bloating caused by small intestinal bacterial overgrowth
US7718608B2 (en) 1999-08-11 2010-05-18 Cedars-Sinai Medical Center Methods of treating a subject suffering from irritable bowel syndrome
US7935799B2 (en) 1999-08-11 2011-05-03 Cedars-Sinai Medical Center Methods of treating diarrhea caused by small intestinal bacterial overgrowth
US8197805B2 (en) 1999-08-11 2012-06-12 Cedars-Sinai Medical Center Methods of treating autoimmune diseases caused by small intestinal bacterial overgrowth
US8388935B2 (en) 1999-08-11 2013-03-05 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US8562952B2 (en) 1999-08-11 2013-10-22 Cedars-Sinai Medical Center Methods for manipulating satiety
US9358276B2 (en) 1999-08-11 2016-06-07 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US7608245B2 (en) 2000-04-10 2009-10-27 Cedars-Sinai Medical Center Methods for manipulating satiety
US7615207B2 (en) 2000-04-10 2009-11-10 Cedars-Sinai Medical Center Methods for treating irritable bowel syndrome

Also Published As

Publication number Publication date
EP1025109A1 (fr) 2000-08-09
AR017366A1 (es) 2001-09-05
ZA989556B (en) 1999-04-20
WO1999020633A1 (fr) 1999-04-29
AU9633098A (en) 1999-05-10
TW407160B (en) 2000-10-01
JP2001520231A (ja) 2001-10-30
CO4990933A1 (es) 2000-12-26
FR2769915A1 (fr) 1999-04-23

Similar Documents

Publication Publication Date Title
FR2769915B1 (fr) Derives d'indazole tricycliques, leur preparation et leur application en therapeutique
FR2728900B1 (fr) Derives de 3-phenylisoquinolein-1(2h)-one, leur preparation et leur application en therapeutique
FR2766823B1 (fr) Derives de 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b] indole-1-acetamide, leur preparation et leur application en therapeutique
FR2756563B1 (fr) Derives de benzoate de 1,4-diazabicyclo[2.2.2]oct-2-yl- methyle, leur preparation et leur application en therapeutique
FR2771093B1 (fr) Derives d'imidazole, leur preparation et leur application en therapeutique
FR2792318B1 (fr) Derives d'indazole, leur preparation et leur application en therapeutique
FR2758329B1 (fr) Derives d'imidazole-4-butane boronique, leur preparation et leur utilisation en therapeutique
FR2737494B1 (fr) Derives de benzenesulfonamide, leur preparation et leur application en therapeutique
FR2765874B1 (fr) Derives de 6-pyrrolidin-2-ylpyrindines, leur preparation et leur application en therapeutique
FR2761068B1 (fr) Derives de piperazin-4-ylthieno[3,2-c]pyridin-4-yl-2- carboxamide, leur preparation et leur application en therapeutique
FR2753196B1 (fr) Derives d'indazole tricyclique, leur preparation et leur application en therapeutique
FR2772378B1 (fr) Derives d'imidazole, leur preparation et leur application en therapeutique
FR2765582B1 (fr) Derives de 3-alkyl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one leur preparation et leur application en therapeutique
FR2769914B1 (fr) Derives d'indazole tricycliques leur preparation et leur application en therapeutique
FR2761070B1 (fr) Derives de dihydropyrazino[1,2-a]indole-1-one, leur preparation et leur application en therapeutique
FR2765581B1 (fr) Derives de 3-aryl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one, leur preparation et leur application en therapeutique
FR2724382B1 (fr) Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique
FR2777566B1 (fr) Derives d'azacycloalcanes, leur preparation et leur application en therapeutique
FR2741072B1 (fr) Derives d'oxazolidin-2-one, leur preparation et leur application en therapeutique
FR2735776B1 (fr) Derives de 2,3-dihydro-1h-indole, leur preparation et leur application en therapeutique
FR2759698B1 (fr) Derives de 1,4-diphenylimidazole-5-acetamide, leur preparation et leur application en therapeutique
FR2785903B1 (fr) Derives de 1-aminoethylquinoleine, leur preparation et leur application en therapeutique
FR2765580B1 (fr) Derives de (1h-imidazol-4-yl)piperidine, leur preparation et leur application en therapeutique
FR2731707B1 (fr) Derives de benzimidazole, leur preparation et leur application en therapeutique
FR2722501B1 (fr) Derives de 9h-imidazo(1,2-a)benzimidazole-3-acetamide, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse